# GLIMEPIRIDE
> **ANDA202112** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2013-04-17
## Drug
- **FDA Application Number:** ANDA202112
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GLIMEPIRIDE
- **Generic name:** GLIMEPIRIDE
- **Active ingredients:** GLIMEPIRIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **Manufacturer:** Florida Pharmaceutical Products, LLC
- **First approval:** 2013-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202112)
---
*AI Analytics · CC0 1.0*